Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family - Wikidata - wikimedia - TriplyDB

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

http://www.wikidata.org/entity/Q24670173

about

AID and APOBECs span the gap between innate and adaptive immunity HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies Antiretroelement activity of APOBEC3H was lost twice in recent human evolution Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1 Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1 The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors HIV-1 Vif, APOBEC, and intrinsic immunity Human cytidine deaminase APOBEC3H restricts HIV-1 replication Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity Cytidine deamination induced HIV-1 drug resistance Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all The APOBEC3 family of retroelement restriction factors Suppression of APOBEC3-mediated restriction of HIV-1 by Vif Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction L1 retrotransposons, cancer stem cells and oncogenesis Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n APOBEC3G: an intracellular centurion Paradigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif).Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.SIV replication in human cells Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.Demonstration of a novel HIV-1 restriction phenotype from a human T cell line The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization.Functions and regulation of the APOBEC family of proteins Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication.Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.Determinants of sequence-specificity within human AID and APOBEC3G Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.

P2860

Q21131084-AE1D6A05-CA5D-4750-8BBD-4F70A1DFD1E1 Q24297395-97ABB981-899A-442E-B36D-AA1E3FCEF7CA Q24311460-496269D8-20FB-4A27-B5A4-1105BD2BF0A1 Q24317568-1672B0B5-6C9A-405A-8134-DD8B2E0A0080 Q24321636-BF4ADE41-F7CC-4271-9044-1C83024D93BC Q24596322-A20AE1A3-D250-47B5-9DD5-E236A38F28B1 Q24612992-2CA9B21D-170A-455B-B45D-26911FEB07FB Q24619114-6F1EBEE3-FCB6-4940-AFEC-8407EDBF07B1 Q24647833-0646E6C6-8CA6-4E2D-83FC-72F0A4D382CE Q24653682-BC3B6F31-3B50-4C31-A4E5-21FC9D2BA1D9 Q24655418-49E30C16-6F1A-46AB-95E6-84B68A79ECF9 Q24656551-D3A3D965-E3FF-472F-8FFD-800E699E0732 Q24657298-792BC7A4-6FB1-42FE-9125-260E9623A7B8 Q24672209-B447266A-05BD-499F-AEE6-A811948E0726 Q24675735-722914FD-484D-432C-B7CE-3CBF217308DC Q26823568-4085C436-59C3-405A-93B6-1C5CA7FAEFC0 Q26862780-95DDDC57-A31B-40F8-89F5-2558D1A873C6 Q27025150-BAF37A1A-30BC-4D03-AB94-317897D62BF1 Q27680506-EEF44161-2D11-4E83-BCEB-D7D4D635CF39 Q27680599-531A177C-2DA5-470A-B6F5-ED16A2CFAB36 Q28394080-293EE9DB-04FB-4A88-BC99-CEFBA1162475 Q28481286-A5578FF3-4E44-4679-8D2E-D7878291DA46 Q28754989-F8FD13DE-B44E-4CDB-9AA6-1AEF98B6D3DF Q30362641-7B7F5B19-3088-4C18-8C06-23014805A522 Q30381745-678635B7-007B-4B48-BCCC-9203316C7E2F Q30417737-F93FA2F4-D5D8-4BEB-96C5-A77835360751 Q30483676-CE347134-762E-4F31-B0EB-D2680ABAF5FB Q31078477-28EF7549-C8CE-45D2-976C-90B9636D57C5 Q33349452-BE2C8CB0-1168-4272-99C4-AF55DD7B91D5 Q33355942-C3D23673-A5A8-4AC7-8D91-5D058FD331BC Q33385376-88852326-5E7F-4DD1-8011-0D7DBAA1D646 Q33393637-32B001BC-5406-4B7E-B940-3E2552F51C00 Q33558327-A4A61CFF-929B-421C-BC53-9B5C683DB39C Q33595661-9BAD73E4-9E09-43F3-89A5-B176EE90ED26 Q33654949-898FD89D-7C18-4EEE-B17A-A3A4F154A89C Q33815187-E8A9295C-9D32-4150-A442-A4AAB0A74239 Q33825197-57055AD2-C1EB-45E4-BC67-E2518CF04F5D Q33877364-6051D68B-6AF1-47BB-A20E-BC1691BC6941 Q33885890-D64557D4-6E7A-4B86-917F-ACB4F592B47C Q33925040-F63EC76F-F9FE-47DD-83E7-CEB773BFCD69

P2860

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

http://www.wikidata.org/entity/Q24670173

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@ast

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@en

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@nl

type

label

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@ast

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@en

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@nl

prefLabel

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@ast

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@en

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@nl

P1433

Q24670173-78BBADA4-8EBA-4ED5-B724-9D01B6D00E7F

P1476

Q24670173-BF3F9596-F369-4B3F-B3FA-D78D15F5141F

P2093

Q24670173-234491B7-E884-41AE-A7DF-F9C9BEB0CC2F

Q24670173-6BD90843-AA16-404E-8FC1-69F56A223678

Q24670173-B2F15674-2DD1-4DAF-9733-F3207C03D4AE

Q24670173-F0E4F44E-03B7-4278-82AC-E5A61CD71E63

P2860

Q24670173-0294DAE4-39F5-40BF-8611-9F69A67F8782

Q24670173-090E14C7-B0A3-4F36-B26D-B72E95CCD604

Q24670173-0D274477-C700-4748-BB22-23EC2BCA90CE

Q24670173-0F19BF32-D521-49C6-97C6-189DA74E995E

Q24670173-0FBC9E7B-1D38-42A5-B7AF-C31910B0E12B

Q24670173-13D63B43-50A6-4DAF-80A1-E5A506A5ED07

Q24670173-142E5E7C-5B67-4DDD-AB7F-08979CE22866

Q24670173-1D12828F-1CAD-4136-BCDF-628EE5F240D1

Q24670173-269B7B2B-28F5-4A90-9F7B-552CB16733F4

Q24670173-29C3B776-B7EF-4C52-813E-DAAC89D74F6C

P304

Q24670173-C915C89F-D076-4079-9ADD-FBE115ADA639

P31

Q24670173-994F5D3A-AB7F-4B9A-BEA7-3DE245AEC9F7

P3181

Q24670173-7A49BA61-88B7-4FD8-B768-C60AE59F5B89

P356

Q24670173-FC62F3D8-1BFD-4BD8-9E7F-90862EB1E2F0

P407

Q24670173-7574A66A-9B42-411D-B427-9664057183AD

P433

Q24670173-2C1E8A95-E240-43B5-A75F-E273CC99A70D

P478

Q24670173-8D82C6E0-24DD-4767-91D9-532F52623CA1

P577

Q24670173-6A87EAC3-6163-441B-8CE7-EE7DC0906EBC

P698

Q24670173-E2E2B7B3-75EE-4924-BD70-480EA4D9A649

P921

Q24670173-9504AB80-ED2D-4BA1-8577-1926CF412A1E

P932

Q24670173-3F845127-994F-4C44-9FF4-FB53F59A9823

P3181

P356

P1433

Journal of Virology

P1476

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

@en

P2093

Walter J Esselman

http://www.w3.org/2001/XMLSchema#string

Xiaojun Wang

http://www.w3.org/2001/XMLSchema#string

Ying Dang

http://www.w3.org/2001/XMLSchema#string

Yong-Hui Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities

Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

P304

10522-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3024731

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01123-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16920826

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

1641744

http://www.w3.org/2001/XMLSchema#string